34th Annual International Prostate Cancer Update

Grand Hyatt Vail  •  Vail, Colorado
February 11-14, 2024

innovations in urologic practice logo

GRU Presents the 34th International Prostate Cancer Update

The International Prostate Cancer Update (IPCU), is a multi-day, CME-accredited conference focused on new developments in prostate cancer treatment, diagnosis, and prevention. IPCU 34 will feature lectures, interactive discussions, panel roundtables, debates, and case reports. This conference is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer.

The goal of this educational program is to equip healthcare professionals involved in the diagnosis and treatment of prostate cancer with the up-to-date clinical knowledge and tools they need to best treat their patients. The program will discuss the treatment of prostate cancer from diagnosis to treating advanced and metastatic disease. The conference aims to give physicians exposure to a comprehensive review of treating prostate cancer patients and to give them a chance to discuss the issues with peers and experts.

Program Director

E. David Crawford, MD

E. David Crawford, MD

Professor of Urology
University of California,
San Diego
La Jolla, California

IPCU Special Guest Speaker

John Elway, the iconic former American football quarterback, is best known for his illustrious 16-year career in the NFL. Before rising to NFL prominence, Elway showcased exceptional talent in both football and baseball at Stanford University, ultimately becoming the #1 pick in the 1983 pro football draft. Elway’s enduring impact on the NFL was most evident during his tenure with the Denver Broncos. Serving as the team’s quarterback and later as the Vice President of Football Operations and General Manager, he played a pivotal role in the Broncos’ success, winning a combined three Super Bowl Championships. As a player, his exceptional skills, marked by a powerful arm and unwavering composure, propelled the Broncos to five Super Bowl appearances, clinching victories in Super Bowl XXXII and XXXIII. He captured Super Bowl 50 as the General Manager.

Off the field, Elway has been equally successful, as an entrepreneur. He has been in the automotive business for nearly 40 years, currently owning 6 different Elway dealerships, as well as several successful motorsports stores. He currently has four restaurants in Colorado which bear his name. And for good measure, he owns 7Cellars, a rapidly growing wine company.  He has made significant philanthropic contributions, particularly in supporting prostate cancer research and awareness programs. His legacy as a versatile athlete, strategic football executive, entrepreneur, and compassionate humanitarian continues to inspire generations.

John Elway

John Elway

Legendary Denver Broncos Quarterback

Agenda

The International Prostate Cancer Update offers a comprehensive update on the treatment of prostate cancer. Join us from February 11-14, 2024, in Vail, Colorado.

This is a working agenda and subject to change. Please check back often for the latest updates.

TimeCourse TitleSpeaker(s)
SUNDAY, FEBRUARY 11, 2024 (ALL TIMES MOUNTAIN STANDARD TIME)
3:00pm–5:00pmIPCU 34 RegistrationCascade Ballroom E
4:30pm–4:35pmWelcome and Opening RemarksE. David Crawford, MD
4:35pm–5:30pmSession 1: Managing the Side Effects of Androgen Deprivation TherapyModerators: Scott B. Sellinger, MD, and E. David Crawford, MD
4:35pm–4:50pmCardiovascular Side EffectsRobert H. Eckel, MD, FAHA, FACC, FNLA
4:50pm–5:00pmBone Health and Non-cardiovascular Side Effects of ADTScott B. Sellinger, MD
5:00pm–5:10pmImplementing Changes in Patient BehaviorJason M. Hafron, MD
5:10pm–5:25pmPanel Discussion / Q&AModerator: Scott B. Sellinger, MD, Panelists: David M. Albala, MD, Robert H. Eckel, MD, FAHA, FACC, FNLA, Jason M. Hafron, MD
5:25pm–5:30pmSession 1 Selected AbstractsModerator: Scott B. Sellinger, MD
5:30pm–6:00pmIndustry-supported Symposium: Prostate 360E. David Crawford, MD
6:00pm–7:30pmIPCU / LUGPA Welcome Reception
MONDAY, FEBRUARY 12, 2024 (ALL TIMES MOUNTAIN STANDARD TIME)
7:00am–7:10amWelcome and Introductory RemarksE. David Crawford, MD
7:10am–8:10amSession 2: Molecular Targeted Imaging (MTI)Moderators: Phillip J. Koo, MD
7:10am–7:25amMolecular Targeted ImagingPhillip J. Koo, MD
7:25am–7:35amClinical Impact of PSMA PET Prior to ProstatectomyRobert E. Reiter, MD
7:35am–7:45amImaging and rhPSMASean P. Collins, MD, PhD
7:45am–7:55amChallenging Case Discussion: Molecular Targeted ImagingRobert E. Reiter, MD
7:55am–8:05amPanel Discussion/ Q&AModerator: Phillip J. Koo, MD, Panelists: Wayne G. Brisbane, MD, Sean P. Collins, MD, PhD, Robert E. Reiter, MD
8:05am–8:10amSession 2 Selected Abstracts
8:10am–9:10amIndustry-supported Educational Breakfast Program: PSMA-Targeted PET Imaging and Radioligand Therapy in the Management of Prostate Cancer: What Urologists Need to KnowStephen Rowe, MD, PhD
9:10am–9:25amBreak & Visit Exhibits
9:25am–10:30amSession 3: LUGPA - Health Policy and Political AdvocacyModerator: Scott B. Sellinger MD
9:25am–9:45am2024 Legislative and Regulatory UpdatesDavid M. Albala, MD, and Mara R. Holton, MD
9:45am–10:00amPanel Discussion: Political Advocacy– Be at the Table or be On the Menu!Evan R. Goldfischer, MD, MBA, FACS, Jason M. Hafron, MD, Richard G. Harris, MD, FACS, R. Jonathan Henderson, MD, Ronald P. Kaufman, Jr., MD, Jeffrey M. Spier, MD
10:00am–10:25amPanel Discussion: Health Policy and Political AdvocacyDavid M. Albala, MD, Evan R. Goldfischer, MD, MBA, FACS, Jason M. Hafron, MD, Richard G. Harris, MD, FACS, R. Jonathan Henderson, MD, Mara R. Holton, MD, Ronald P. Kaufman, Jr., MD, Scott B. Sellinger MD, Jeffrey M. Spier, MD,
10:25am–10:30amSession 3 Selected Abstracts
12:00pm-1:00pmIndustry-supported Educational Lunch Program: A GnRH Antagonist Treatment Option for Advanced Prostate CancerE. David Crawford, MD
10:30am–3:15pmFree Time / Attendee Interaction
2:00pm–3:00pmTriangle of Pain
3:15pm–4:00pmIndustry-supported Educational Program: A Combination Therapy for Certain Patients with metastatic Castration-resistant Prostate Cancer (mCRPC)David S. Morris, MD
4:00pm–4:30pmBreak & Visit Exhibits
4:30pm–7:00pmSession 4: Germline, Molecular Detection, and ScreeningModerator: David M. Albala, MD
4:30pm–4:40pmPutting Germline Testing into Context: A Primer and Current KnowledgeAlan H. Bryce, MD
4:40pm–4:50pmPros and Cons of the REIMAGINE TrialMatthew R. Cooperberg, MD, MPH (Virtual)
4:50pm–5:00pmDebate: The Role of Germline Genetics in Prostate Cancer Screening (Pro)Brian T. Helfand, MD, PhD
5:00pm–5:10pmDebate: The Role of Germline Genetics in Prostate Cancer Screening (Con)Sigrid V. Carlsson, MD, PhD, MPH
5:10pm–5:20pmThe Future of AI in Pathologic Evaluation of Prostate CancerFrancisco G. LaRosa, MD, FCAP
5:20pm–5:50pmPanel: Guidelines and Treatment for Early DetectionModerator: Matthew R. Cooperberg, MD, MPH (Virtual), Panelists: David M. Albala, MD, Alan H. Bryce, MD, Robert H. Eckel, MD, FAHA, FACC, FNLA, Richard G. Harris, MD, FACS, Francisco G. LaRosa, MD, FCAP,
5:50pm–5:55pmSession 4 Selected Abstracts
5:55pm–6:10pmBreak & Visit Exhibits
6:10pm–6:25pmMolecular Detection and ScreeningAdam B. Murphy, MD, MBA, MSCI (virtual)
6:25pm–6:40pmAlan Partin Lecture: The Genomics and Natural History of Visible vs. Invisible CancersLaurence Klotz, MD, FRCSC
6:40pm–6:55pmPanel Discussion/ Q&AModerator: Laurence Klotz, MD, FRCSC, Panelists: Sigrid V. Carlsson, MD, PhD, MPH, Sean P. Collins, MD, PhD, John W. Davis, MD, Francisco G. LaRosa, MD, FCAP
6:55pm–7:00pmSession 4 Selected Abstracts
7:00pm–9:00pmTrivia Night
TUESDAY, FEBRUARY 13, 2024 (ALL TIMES MOUNTAIN STANDARD TIME)
7:00am–8:10amSession 5: Approaches in Local Therapy for Prostate CancerModerator: Peter J. Rossi, MD
7:00am–7:15amHigh Resolution Micro-ultrasound vs. MRI for Staging and DiagnosisLaurence Klotz, MD, FRCSC
7:15am–7:30amBrian Moran Distinguished Lecture: Mobilizing Moran’s Army from Seed to Shining SeedPeter F. Orio III, DO, MS
7:30am–7:40amAblative Local Technologies (HIFU, Cryo, SBRT, Laser, and other Forms of Energy)David M. Albala, MD
7:40am–8:05amPanel Discussion: Choosing the Right Modality for Your PatientModerator: A. Karim Kader, MD, PhD, FRCSC, Panelists: John W. Davis, MD, R. Jonathan Henderson, MD, Laurence Klotz, MD, FRCSC, Michael A. Liss, MD, PhD, MAS, FACS, Peter F. Orio III, DO, MS, Robert E. Reiter, MD
8:05am–8:10amSession 5 Selected Abstracts
8:10am–9:00amIndustry-supported Educational Breakfast Program: Treatment Intensification with XTANDI (Enzalutamide) for Patients with Metastatic Castration-Sensitive Prostate Cancer and Nonmetastatic Castration-Sensitive Prostate Cancer with Biochemical Recurrence at High Risk for MetastasisLawrence Karsh, MD
9:00am–9:15amBreak & Visit Exhibits
9:15am–10:30amSession 6: High-risk Localized and Oligometastatic DiseaseModerator: Christopher J. Kane, MD
9:15am–9:30amTreatment of Oligometastatic Prostate Cancer in the Era of PSMA PET ImagingAndrew W. Hahn, MD
9:30am–9:40amHigh-risk Localized and Oligometastatic DiseaseChristopher J. Kane, MD
9:40am–9:50amRationale for Involved Site SBRT-Enhanced Intermittent Androgen Deprivation Therapy in Nodal Oligorecurrent Prostate CancerSean P. Collins, MD, PhD
9:50am–10:00amRole of Molecular Targeted Imaging in Oligometastatic DiseasePhillip J. Koo, MD
10:00am–10:25amPanel Discussion/ Q&AModerator: Phillip J. Koo, MD, Panelists: Sean P. Collins, MD, PhD, Christopher J. Kane, MD, Robert E. Reiter, MD, Peter J. Rossi, MD
10:25am–10:30amSession 6 Selected Abstracts
10:30am–10:50amPatient Panel Discussion
12:00pm-1:00pmIndustry-supported Educational Lunch Program: A Treatment Option for Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC) PatientsBryan A. Mehlhaff, MD
10:50am–3:15pmFree Time / Attendee Interaction
3:15pm–4:00pmIndustry-supported Educational Program: Getting Ahead of Advanced Prostate CancerSpeakers: Robert E. Reiter, MD, and Timothy Richardson, MD
4:00pm–4:30pmVisit Exhibits
4:30pm–5:35pmSession 7: Advanced Prostate Cancer IModerator: Alan H. Bryce, MD
4:30pm–4:45pmChoosing Systemic Therapy for Men with Metastatic Hormone Sensitive Prostate CancerAndrew W. Hahn, MD
4:45pm–4:55pmDoublets and Triplets: Patient SelectionDavid S. Morris, MD, FACS
4:55pm–5:05pmAPC Clinics and PathwaysJeffrey M. Spier, MD, and Travis Mendel, MD
5:05pm–5:15pmFinancial Toxicity of APC ManagementR. Jonathan Henderson, MD
5:15pm–5:30pmChallenging Case DiscussionModerator: Alan H. Bryce, MD, Panelists: Andrew W. Hahn, MD, R. Jonathan Henderson, MD, Mara R. Holton, MD, Daniel P. Petrylak, MD,Scott B. Sellinger, MD
5:30pm–5:35pmSession 7 Selected Abstracts
5:35pm–6:50pmSession 8: BPH, Prostatitis, and Other Co-occurrencesModerator: Brian T. Helfand, MD, PhD
5:35pm–5:50pmThe Microbiome and Prostate CancerMichael A. Liss, MD, PhD, MAS, FACS
5:50pm–6:00pmTherapeutic Modalities for BPHBrian T. Helfand, MD, PhD
6:00pm–6:10pmPathological Aspects of BPH, Prostatitis, and Other Painful Co-occurrencesFrancisco G. LaRosa, MD, FCAP
6:10pm–6:20pmOptilume for BPH: Considerations for UseRyan P. Terlecki, MD, FACS
6:20pm–6:45pmPanel Discussion/ Q&AModerator: Brian T. Helfand, MD, PhD, Panelists: Alan H. Bryce, MD, Francisco G. LaRosa, MD, FCAP, Michael A. Liss, MD, PhD, MAS, FACS, David S. Morris, MD, FACS
6:45pm–6:50pmSession 8 Selected Abstracts
7:00pm–8:00pmExhibit Hall Social
8:00pm–10:00pm34th Anniversary Networking and Awards DinnerSpecial Guest Speaker: John Elway
WEDNESDAY, FEBRUARY 14, 2024 (ALL TIMES MOUNTAIN STANDARD TIME)
7:00am–8:05amSession 9: Advanced Prostate Cancer IIModerator: Daniel P. Petrylak, MD
7:00am–7:15amUpdates on mCRPCAlan H. Bryce, MD
7:15am–7:25amAssessing and Managing Metabolic Risk in Patients with Prostate CancerRobert H. Eckel, MD, FAHA, FACC, FNLA
7:25am–7:35amPARPi in mCRPCDaniel P. Petrylak, MD
7:35am–7:45amIntegrating Care in APCJohn W. Davis, MD
7:45am–8:00amPanel Discussion/ Q&AModerator: Andrew W. Hahn, MD, Panelists: Robert H. Eckel, MD, FAHA, FACC, FNLA, Evan R. Goldfischer, MD, MBA, FACS, Richard G. Harris, MD, FACS, Arturo Mendoza-Valdes, MD
8:00am–8:05amSession 9 Selected Abstracts
8:05am–8:50amIndustry-supported Educational Breakfast: Exploring The Role Of NUBEQA® (darolutamide) in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Combination With Docetaxel and in Non-metastaticSpeaker: Scott B. Sellinger, MD
8:50am–9:20amBreak & Visit Exhibits
9:20am–10:30amSession 10: Treatment of Prostate Cancer Around the WorldModerator: Phillip J. Koo, MD
9:20am–9:35amMortality and Prostate Cancer: Updates from MexicoArturo Mendoza-Valdes, MD
9:35am–9:50amUpdates from IndiaKshitij Pandit, MD
9:50am–10:05amUpdates from CanadaLaurence Klotz, MD, FRCSC (virtual)
10:05am–10:20amUpdates from ChinaPeter K.F. Chiu, MD, PhD, FRCSEd (virtual)
10:20am–10:30amPanel Discussion / Q&A
10:30am–11:10amSession 11: Late-Breaking PresentationsModerators: R. Jonathan Henderson, MD, and Mara R. Holton, MD
10:30am–10:40amMRI-invisible Prostate Cancer and Use of Biomarkers to Identify Potential CandidatesPriya N. Werahera, PhD
10:40am–10:50amArtificial Intelligence and Extended Reality for Urology TrainingNelson N. Stone, MD
10:50am–11:00amAI in Healthcare: The Hype, The Reality and the PromiseA. Karim Kader, MD, PhD, FRCSC
11:00am–11:10amHow to Use Natural Ligands to Kill Tumor Stem CellsStephen B. Howell, MD
11:10am–11:30amAbstract Presentations
11:30am–11:40amClosing RemarksE. David Crawford, MD
11:40am–12:20pmFuture Directions in Prostate Cancer (Non-CME)
11:40am-11:50amPromaxo MRI SystemPrithipal Sethi, MD
11:50am-12:00pmBioProtect Balloon Implant™ SystemDaniel Y. Song, MD
12:00pm–12:10pmGallium 68-PSMA-11 Indications for Prostate Cancer PET/CT ScanningBradley Fehrenbach, MD, MBA
12:10pm–12:20pmFirst Patient with Metastatic Prostate Cancer to Receive 2 Doses of Cu-67 SAR-bisPSMA: A Case ReportLuke T. Nordquist, MD
12:20 PMAdjourn

Help us promote IPCU 34!

We’ve built a social media toolkit to help you spread the word about the meeting to your friends and colleagues. We hope you’ll help us generate awareness because we all benefit from getting together and learning. Thanks!

Accommodations

The Grand Hyatt Vail room block for the conference is sold out.

Overflow Hotels for the International Prostate Cancer Update or visit Hotels.com

Highline Vail – a DoubleTree by Hilton
2211 North Frontage Road
Vail, Colorado, 81657
970-476-2739

Highline Vail is minutes from Vail Mountain and 1 mile from the Grand Hyatt Vail hotel. They offer ski and bike rentals, with a shuttle service to three lift access points in Vail Village — the closest is only a mile away. Unwind after a day on the slopes with a massage, and warm up by the fireplace on the patio. Every stay starts with a warm chocolate chip cookie.

Lion Square Lodge Condos
660 Lionshead Place #5295
Vail, Colorado 81657
800-863-8415

Located in the charming Bavarian-style Lionshead Village, the lodge is surrounded by shopping, dining, and entertainment. Visitors from all over the world flock to this luxury retreat, whether they’re seeking a wonderland of winter sports, a summer outdoor adventure, or just to experience ultimate relaxation. Choose from cozy hotel rooms or deluxe lodges—there’s something to suit every vacationer.

Transportation

AIRPORT TRANSPORTATION:
Transportation to and from the airport can be made via the following:
https://www.epicmountainexpress.com/
https://www.aspenvaillimo.com/about-blinexpress/

Lyft and Uber now servicing Eagle County Regional Airport
https://www.vailvalleypartnership.com/2022/05/lyft-and-uber-now-servicing-eagle-county-regional-airport/

PARKING:
Nightly Valet Parking: $55 per vehicle

Activities

Snowmobiling

Tour begins just 5 minutes from the heart of Vail Village. The expansive terrain has open meadows, daily groomed trails, winding single-track, and stunning views. Guides have years of experience snowmobiling and navigating the terrain. Two-hour, half-day, and private tours are available.

More Information

Skiing, Snowboarding, and Snowshoeing

The Grand Hyatt Vail ski rental shop is a ski valet location for all of our guests, situated right next to the Vail Cascade lift. A true luxury ski-in/ski-out experience where you will be greeted with a warm beverage and toasty boots in the ski lounge next to the fireplace. They will even carry your skis to and from the chair lift.

More Information

Dog Sledding

Take a breathtaking adventure through the snow on a dog sled. These magnificent huskies will “mush” you through the backcountry scenery on a two-person sled. Contact our Concierge Team at 970.476.1234 for more details.

More Information

Ice fishing and Winter Fly-Fishing

Ice fishing and Winter Fly-Fishing in the High Country of the Colorado Rockies are unique activities and a great way to get out and enjoy the winter landscape. You never know what is going to bite below the ice when you’re located on a great pinnacle or ledge just off the deep shoreline. Speak with our concierge at 970.476.1234 about booking this experience.

More Information

Snow Tubing at Epic Discovery

Fly down the tubing course at the top of Vail Mountain with Vail’s Epic Discovery. Located at the top of the Eagle Bahn Gondola. Tickets must be purchased in advance. Vail’s Epic Disocovery is located 19.6 miles away from the hotel.

More Information

Snow Coach Tours

This heated adventure is perfect for those who want to enjoy the beauty of the Rockies in the winter! Travel in warmth and comfort in a fully enclosed, heated vehicle that maneuvers over the snow. Enjoy views of the White River National Forest. Nova Guides is located 19.6 miles away from the hotel.

More Information

CME Information

In support of improving patient care, this activity will be planned and implemented by Medical Education Resources (MER) and Carden Jennings Publishing. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for healthcare teams.

This conference will be accredited for an estimated 13 AMA PRA Category 1 Credits™, 13 ANCC nursing contact hours, as well as 13 AAPA Category 1 CME Credits.

Registration

By registering for this conference, you agree to our standard Conference Registration and Attendance Terms and Conditions agreement, which is available online at: Conference Registration and Attendance Terms and Conditions.

REGISTRATION NOTES:
  • If using, the promo code goes at the top left before the ticket list.
  • Please scroll through all the ticket options before making a selection.
  • Review the form before submitting it to make sure that all required information is supplied.

Requests for registration refunds must be received by email at meetings@grandroundsinurology.com by at least 30 business days before the activity begins (December 28, 2023). Requests received after the refund deadline will not be processed. Cancellations are subject to a $100 administrative fee deducted from the registration fee paid to cover guarantees and other expenses. Requests should be emailed to meetings@grandroundsinurology.com. The organizer reserves the right to cancel activities, not less than 10 business days before the scheduled date, if extenuating circumstances make it necessary. Registrants will be notified by email given at registration.

Abstract Submission

1. When is the abstract submission deadline?
January 5, 2024

2. What are the submission guidelines?
When submitting your abstract, please follow these formatting guidelines:

  1. Include a title
  2. Maximum of 500 words
  3. Single-spaced
  4. 10-point font
  5. Times New Roman
  6. Author names must be spelled out
  7. List the institution, city, state, country, and e-mail address of the presenting author
  8. To submit your abstract, e-mail your document to David Utz at dutz@cjp.com and Greg Donohue at gdonohue@cjp.com.

3. How will the posters be displayed?
After your abstract is submitted and approved, please send a recording (3 minutes or shorter, MP4 or MOV format) to  of someone presenting the poster. This is usually done by an author of the abstract, but is not required. Zoom has an easy self-recording option with screen share for the abstract slides. Please also send bio information about the presenter of the abstract.

4. Who can give the oral poster presentation?
Anyone involved with the poster; does not need to be a lead investigator or healthcare provider. However, please provide the name of the presenter to us in advance, by January 5, if possible.

5. Are the poster sessions CME accredited?
No

6. I have other questions, who can I contact?
Greg at gdonohue@cjp.com

NOTE: The posters will also be printed in an abstract book. Along with the abstract slide image itself, text similar to the following will be printed in the abstract book:

Support Opportunities

To inquire about support opportunities, please contact:

Marc Weathersby, Chief Commercial Officer
Tel:434-817-2000, x193    Cell: 434-989-5508
Fax 434-817-2020    mweathersby@cjp.com

Exhibit and Sponsor Prospectus

Meeting organized by Grand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd.

Jointly provided by Medical Education Resources (MER) and Carden Jennings Publishing Co., Ltd.

View content from previous International Prostate Cancer Update Meetings